Biography
Biography: Bill W. Massey
Abstract
Advances in pharmacogenetic testing and personalized medicine are beginning to translate into clinical practice. The promise of these advances to improve patient outcomes and reduce cost of care are just being realized, however, an impediment to their rapid adoption has been the novelty of this information and the lack of understanding how to use it in normal clinical practice. As more pharmacogenetic discoveries are made, the information becomes more complex. This is especially true of combinatorial pharmacogenetics which considers multiple genes as they affect response to a particular drug. This lecture will provide a brief overview of pharmacogenetics with special attention to combinatorial pharmacogenetics and as to how this information can be used in clinical decision-making.